These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 8626128

  • 1. p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes.
    Zheng W, Cao P, Zheng M, Kramer EE, Godwin TA.
    Gynecol Oncol; 1996 May; 61(2):167-74. PubMed ID: 8626128
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
    Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW.
    Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
    [Abstract] [Full Text] [Related]

  • 3. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
    Zheng W, Liang SX, Yu H, Rutherford T, Chambers SK, Schwartz PE.
    Int J Surg Pathol; 2004 Jul; 12(3):207-23. PubMed ID: 15306933
    [Abstract] [Full Text] [Related]

  • 4. BCL-2 and P53 expression in endometrial carcinoma.
    Erkanli S, Eren F, Pekin S, Bagis T.
    J Exp Clin Cancer Res; 2004 Mar; 23(1):97-103. PubMed ID: 15149157
    [Abstract] [Full Text] [Related]

  • 5. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T.
    Cancer; 2002 Jun 01; 94(11):2935-40. PubMed ID: 12115382
    [Abstract] [Full Text] [Related]

  • 6. p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma.
    Bancher-Todesca D, Gitsch G, Williams KE, Kohlberger P, Neunteufel W, Obermair A, Heinze G, Breitenecker G, Hacker NF.
    Gynecol Oncol; 1998 Oct 01; 71(1):59-63. PubMed ID: 9784320
    [Abstract] [Full Text] [Related]

  • 7. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
    Al Kushi A, Lim P, Aquino-Parsons C, Gilks CB.
    Mod Pathol; 2002 Apr 01; 15(4):365-71. PubMed ID: 11950909
    [Abstract] [Full Text] [Related]

  • 8. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G, Gnetti L, Merisio C, Melpignano M.
    Maturitas; 2007 Feb 20; 56(2):190-7. PubMed ID: 16963204
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.
    Kokawa K, Shikone T, Otani T, Nishiyama R, Ishii Y, Yagi S, Yamoto M.
    Gynecol Oncol; 2001 May 20; 81(2):178-83. PubMed ID: 11330946
    [Abstract] [Full Text] [Related]

  • 10. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T, Miller E, Duska L, Oliva E.
    Am J Surg Pathol; 2012 May 20; 36(5):753-61. PubMed ID: 22498825
    [Abstract] [Full Text] [Related]

  • 11. The association between p53 expression, stage and histological features in endometrial cancer.
    Ragni N, Ferrero S, Prefumo F, Muschiato B, Gorlero F, Gualco M, Fulcheri E.
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov 01; 123(1):111-6. PubMed ID: 15894417
    [Abstract] [Full Text] [Related]

  • 12. MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma.
    Ambros RA, Sheehan CE, Kallakury BV, Ross JS, Malfetano J, Paunovich E, Figge J.
    Mod Pathol; 1996 Dec 01; 9(12):1165-9. PubMed ID: 8972476
    [Abstract] [Full Text] [Related]

  • 13. A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma.
    Kowalski LD, Kanbour AI, Price FV, Finkelstein SD, Christopherson WA, Seski JC, Naus GJ, Burnham JA, Kanbour-Shakir A, Edwards RP.
    Cancer; 1997 Apr 15; 79(8):1587-94. PubMed ID: 9118043
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A, Ioachim E, Kitsou E, Vougiouklakis T, Zagorianakou N, Makrydimas G, Stefanaki S, Agnantis NJ.
    In Vivo; 2003 Apr 15; 17(5):469-77. PubMed ID: 14598611
    [Abstract] [Full Text] [Related]

  • 15. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
    Hu WF, Liu MQ, Zhao Q.
    Ai Zheng; 2004 Sep 15; 23(9):1021-5. PubMed ID: 15363194
    [Abstract] [Full Text] [Related]

  • 16. p53 as a prognostic indicator in endometrial cancer.
    Geisler JP, Wiemann MC, Zhou Z, Miller GA, Geisler HE.
    Gynecol Oncol; 1996 May 15; 61(2):245-8. PubMed ID: 8626141
    [Abstract] [Full Text] [Related]

  • 17. Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia.
    Furihata M, Sonobe H, Ohtsuki Y, Yamashita M, Morioka M, Yamamoto A, Terao N, Kuwahara M, Fujisaki N.
    J Pathol; 1996 Feb 15; 178(2):133-9. PubMed ID: 8683378
    [Abstract] [Full Text] [Related]

  • 18. Bcl-2 and p53 expression in stage I endometrial carcinoma.
    Giatromanolaki A, Sivridis E, Koukourakis MI, Harris AL, Gatter KC.
    Anticancer Res; 1998 Feb 15; 18(5B):3689-93. PubMed ID: 9854478
    [Abstract] [Full Text] [Related]

  • 19. Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression.
    Nordström B, Strang P, Lindgren A, Bergström R, Tribukait B.
    Anticancer Res; 1996 Feb 15; 16(2):899-904. PubMed ID: 8687148
    [Abstract] [Full Text] [Related]

  • 20. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W, Slomovitz BM, Celestino J, Chung L, Thornton A, Lu KH.
    Cancer Res; 2003 Oct 01; 63(19):6195-9. PubMed ID: 14559803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.